RxDoctor Payments Data

Jacob Inda, MD

Dermatology · Missoula, MTNPI 1275997827

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 33.7% of the total. Reporting peaked in 2023 at $627 and has fallen 83.0% since, to $107 in 2025. That places this record below the midpoint for dermatology clinicians in MT, where the typical reported total is $1,595.

$1,595in general payments, 2019–2025

Across 67 payments — averaging $23.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$537
  • Galderma Laboratories, L.p.$220
  • Novartis$169
  • Boehringer Ingelheim$125
  • Sanofi$115
  • UCB, Inc.$77
  • plus $353 from 9 others

What the payments were for

  • Food & beverage$1,595100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,595 in reported general payments places this provider in the 50th percentile of 46 dermatology providers in Montana.

See all dermatology providers in Montana

Medicare billing

Part B allowed, 2024
$91,043
Medicare patients
433
Services billed
1,440

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab34$142,287
Ketoconazole167$2,184
Betamethasone Dipropionate12$1,293
Triamcinolone Acetonide94$1,261
Fluocinonide30$1,064
Betamethasone Valerate29$914
Mometasone Furoate28$670
Metronidazole17$660
Doxycycline Monohydrate20$461
Clobetasol Propionate11$258
Clindamycin Phosphate14$241
Hydrocortisone62$237
Minoxidil12$78

Paid to pharmacies, not to this prescriber.

Other dermatology in Missoula

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →